| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.3 |